ETF Stats For February 2016: Count Up, Assets Down
Thirteen new products came to market in February: seven exchange-traded funds (“ETFs”) and six exchange-traded notes (“ETNs”). Closures were on the light side, with just three products being liquidated during the month. The net increase of 10 listings pushes the overall count to 1,863, consisting of 1,659 ETFs and 204 ETNs. Assets declined for the […]
Waiting On The Fed
“There are two types of people who will tell you that you cannot make a difference in this world: those who are afraid to try and those who are afraid you will succeed.” –Ray Goforth Pretty quiet markets today but a few stocks are moving well such as AMZN and a new position of ours, […]
A $1.58 Million Portfolio With No Captain
Has your financial advisor contacted you lately? Although global stock markets (see:VT) have recovered from their earlier in the year losses, they could’ve revealed flaws with your investment portfolio’s design. Often, flaws that are camouflaged by rising markets are exposed and exploited in rocky markets. Ultimately, advisors should take responsibility for the investment recommendations they make and the advice given […]
Does Oracle Have What It Takes To Compete With Amazon?
Photo Credit: May Wong Oracle Corporation (ORCL) Information Technology – Software | Reports March 15, After Market Closes As we close the door on fourth quarter earnings another opens when Oracle (ORCL) reports its FQ3 earnings tomorrow after the market closes, the first report of the Q1 2016 season. Oracle is coming off a better than expected […]
Senseonics IPO: We Are Cautious At This Early Stage
Senseonics Holdings (Pending:SENS) expects to raise at least $55.5 million in its upcoming IPO. Based in Germantown, Maryland, Senseonics Holdings is a medical technology company that designs, develops and commercializes glucose monitoring systems for use by people with diabetes. We previewed SENS on our IPO Insights platform earlier last week. SENS currently trades on the OTCBB under symbol SENH. […]
Chart Of The Week – Biotechs Are Oversold
Biotech stocks have taken a beating the last few months, down roughly 35% since peaking in July of last year. And for good reason I think. Biotech at the top was sporting a pretty rich multiple, 25 times forward earnings for the biotech stocks in the S&P 500 and a lot more than that for […]
3 Reasons To Sell EUR/USD – Structural Bearishness
EUR/USD is beginning to climb down the Draghi-backfire tree but around 1.11, it still remains elevated. The team at Morgan Stanley explain why they expect further downside. Here are their 3 reasons: Here is their view, courtesy of eFXnews: We remain bearish on EUR on a structural basis, looking for a move to parity against USD […]
Singapore It On
If you follow us on Twitter (@360Research), it’s not a secret that we’ve been talking about emerging markets and other international indexes outperforming US stocks. One such market is in Singapore. After seeing the Straits Times index decline 30% over the last year, we’re now seeing new demand enter Singaporean stocks. The Straits Times Index is […]
EC Feeble Arguments Against A Rate Hike
We look forward to a week filled with data including CPI, the Empire Manufacturing report, Housing Starts, Industrial Production, and Existing Home Sales – not to mention the important primary election contests in Ohio and Florida tomorrow. But at the top of the list of important events is the FOMC meeting on Wednesday. The consensus […]
S&P 500 Snapshot: Monday Doldrums Before The Fed Meeting
Before the US market opened Global equities had extended their Friday gains. The Shanghai Composite had risen 1.76% and the Nikkei 1.74%. European indexes were a bit less energetic. The Euro STOXX 50 would subsequently close with a 0.59% gain. But US equities didn’t follow suit. Our benchmark S&P 500 traded in its narrowest range […]
